Advertisement
Financing › Details
Acacia Pharma–Gilde Investment: investment, 201103 financing round Series A totalling $10m incl existing investor Gilde Healthcare
Period | 2011-03-31 | |
Money taker | Acacia Pharma Ltd. | |
Group | Acacia Pharma (Group) | |
Money source | Gilde Healthcare Partners B.V. | |
Product | Baremsis (APD421) | |
Product 2 | venture capital | |
Index term | Acacia Pharma–SEVERAL: investment, 201103 financing round Series A $10m from new investor Lundbeckfond Ventures + existing investor Gilde Healthcare | |
Record changed: 2018-02-21 |
Advertisement
More documents for Acacia Pharma (Group)
- [1] Paion AG. (7/2/20). "Press Release: Paion Announces U.S. FDA Approval of Remimazolam (Byfavo) for the Induction and Maintenance of Procedural Sedation". Aachen....
- [2] Euronext N.V.. (3/5/18). "Press Release: Acacia Pharma Lists on Euronext Brussels". Brussels....
- [3] Acacia Pharma Group Ltd.. (3/2/18). "Press Release: Acacia Pharma Successfully Prices Initial Global Offering at EUR 3.60 per Share Raising EUR40m [Not for US, AU, CA, JP, ZA, et al.]". Cambridge & Indianapolis, IN....
- [4] Acacia Pharma Group Ltd.. (2/5/18). "Press Release: Acacia Pharma Announces Its Intention to Launch an Initial Global Offering and to List Its Shares on Euronext Brussels [Not for US, AU, CA, JP, ZA, et al.]". Cambridge & Indianapolis, IN....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top